DIA.MI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 03:40):

Stats
Today's Volume	12 238.00
Average Volume	193 030
Market Cap	5.31B
EPS	€0.860 ( 2024-05-15 )
Next earnings date	( €1.040 ) 2024-07-28
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	33.76
ATR14	€0.146 (0.15%)

Volume Correlation

Long: 0.26 (neutral)

Short: 0.47 (neutral)

Signal:(36.671) Neutral

DiaSorin S.p.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DiaSorin S.p.A. Correlation - Currency/Commodity

0.54
( weak )

-0.26
( neutral )

0.00
( neutral )

-0.13
( neutral )

-0.08
( neutral )

-0.62
( weak negative )

DiaSorin S.p.A. Financials

Annual	2023
Revenue:	€1.15B
Gross Profit:	€741.19M (64.55 %)
EPS:	€2.87

FY	2023
Revenue:	€1.15B
Gross Profit:	€741.19M (64.55 %)
EPS:	€2.87

FY	2022
Revenue:	€1.36B
Gross Profit:	€900.61M (66.17 %)
EPS:	€4.17

FY	2021
Revenue:	€1.24B
Gross Profit:	€824.77M (66.64 %)
EPS:	€5.44

Financial Reports:

No articles found.

DiaSorin S.p.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

DiaSorin S.p.A.

DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.